ストックスクリーナーアプリを入手
10.23
0.10%
-0.010
アフターアワーズ：
10.01
-0.22
-2.15%
前日終値:
$10.24
開ける：
$10.24
24時間の取引高:
1.12M
Relative Volume:
0.77
時価総額：
$313.80M
収益：
-
当期純損益:
$-29.25M
株価収益率:
-8.6256
EPS:
-1.186
ネットキャッシュフロー:
$-22.80M
1週間 パフォーマンス:
+15.86%
1か月 パフォーマンス:
+29.99%
6か月 パフォーマンス:
+137.35%
1年 パフォーマンス:
+199.12%
1日の値動き範囲:
$9.4001
$10.46
1週間の範囲:
$8.81
$11.41
52週間の値動き範囲:
$1.73
$11.41
Sagimet Biosciences Inc Stock (SGMT) Company Profile
名前
Sagimet Biosciences Inc
セクター
電話
(650) 561-8600
住所
155 BOVET RD., SUITE 303, SAN MATEO
SGMT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SGMT
Sagimet Biosciences Inc
|
10.23 | 329.68M | 0 | -29.25M | -22.80M | -1.186 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.83 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.63 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.79 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
595.19 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.51 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Sagimet Biosciences Inc Stock (SGMT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-24 | 開始されました | Canaccord Genuity | Buy |
| 2024-12-06 | 開始されました | Oppenheimer | Outperform |
| 2024-11-12 | 開始されました | UBS | Buy |
| 2024-06-28 | ダウングレード | Goldman | Buy → Neutral |
| 2024-05-02 | 開始されました | H.C. Wainwright | Buy |
| 2024-03-25 | 開始されました | Leerink Partners | Outperform |
| 2023-08-08 | 開始されました | Goldman | Buy |
| 2023-08-08 | 開始されました | JMP Securities | Mkt Outperform |
| 2023-08-08 | 開始されました | Piper Sandler | Overweight |
| 2023-08-08 | 開始されました | TD Cowen | Outperform |
すべてを表示
Sagimet Biosciences Inc (SGMT) 最新ニュース
How Efficient Is Sagimet Biosciences Inc. at Controlling Operating CostsRisk Limited High Gain Trades - beatles.ru
How high can Sagimet Biosciences Inc. stock price go in 2025Free Weekly Stock Watch With Growth Focus - Newser
Risk adjusted return profile for Sagimet Biosciences Inc. analyzed Tactical Trade Setup With Entry Optimizer - Newser
Risk adjusted return profile for Sagimet Biosciences Inc. analyzed Real-Time Entry Signals for Top Stocks - Newser
Sagimet Biosciences Inc. Company Revenue and Profit Trends: A Deep Dive Strategy Playbook for Risk Controlled Trades - Newser
How Sagimet Biosciences Inc. stock performs during market volatilityFree Investment Plan With Growth Optimization - Newser
Reviewing Sagimet Biosciences (NASDAQ:SGMT) & Eledon Pharmaceuticals (NASDAQ:ELDN) - Defense World
What are analysts’ price targets for Sagimet Biosciences Inc. in the next 12 monthsFinancial News Trend Scanner For Every Investor - jammulinksnews.com
Should I hold or sell Sagimet Biosciences Inc. stock in 2025Consistent triple-digit returns - jammulinksnews.com
How does Sagimet Biosciences Inc. compare to its industry peersMaximize portfolio value with smart investment plans - jammulinksnews.com
What catalysts could drive Sagimet Biosciences Inc. stock higher in 2025Gain insights from top financial experts - jammulinksnews.com
Sagimet Biosciences Inc. Stock Performance After Earnings: Historical InsightsLow Risk Trading Ideas - Newser
Why Sagimet Biosciences Inc. stock attracts strong analyst attentionCapital Efficient Investment Tips - Newser
Sagimet Biosciences Inc. Company Revenue and Profit Trends: A Deep DiveSteady Profit Stock Forecasts - Newser
What makes Sagimet Biosciences Inc. stock price move sharplyFree Consultation - Newser
Sagimet Biosciences (NASDAQ:SGMT) Earns Buy Rating from Analysts at Canaccord Genuity Group - Defense World
Sagimet Biosciences (NASDAQ:SGMT) Coverage Initiated by Analysts at Canaccord Genuity Group - MarketBeat
Sagimet Biosciences Bets Big On First-In-Class Fatty Acid Blockers - Finimize
What analysts say about Sagimet Biosciences Inc. stockPhenomenal wealth increase - PrintWeekIndia
Sagimet Biosciences Inc (SGMT) Stock: Navigating a Year of Volatility - investchronicle.com
Strategic Catalysts and Valuation Upside in Sagimet Biosciences (SGMT): A M&A-Driven Biotech Play - AInvest
Sagimet stock gains as Canaccord starts with Buy (SGMT:NASDAQ) - Seeking Alpha
This Sarepta Therapeutics Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday - Benzinga
Sagimet Biosciences Inc. Stock Analysis and ForecastBreakthrough capital growth - Autocar Professional
Top Executives at Sagimet Biosciences Unload Significant Shares! - TipRanks
What drives Sagimet Biosciences Inc. stock priceMarket-crushing stock picks - Autocar Professional
Sagimet Biosciences Executives Sell Shares to Cover Tax Obligations - TradingView
TMO announces CFO retirement & internal successor effective 2026 | SGMT SEC FilingForm 4 - Stock Titan
Is Sagimet Biosciences Inc. a good long term investmentUnprecedented market success - jammulinksnews.com
what makes sagimet biosciences inc. stock price move sharplyShort Squeeze Radar - Newser
Sagimet Biosciences Inc (SGMT) 財務データ
収益
当期純利益
現金流量
EPS
1.32%
1.06%
大文字化:
|
ボリューム (24 時間):